Literature DB >> 21091186

Infection reduction strategies including antibiotic stewardship protocols in surgical and trauma intensive care units are associated with reduced resistant gram-negative healthcare-associated infections.

Marcus J Dortch1, Sloan B Fleming, Rondi M Kauffmann, Lesly A Dossett, Thomas R Talbot, Addison K May.   

Abstract

BACKGROUND: Resistance to broad-spectrum antibiotics by gram-negative organisms is increasing. Resistance demands more resource utilization and is associated with patient morbidity and death. We describe the implementation of infection reduction protocols, including antibiotic stewardship, and assess their impact on multi-drug-resistant (MDR) healthcare-acquired gram-negative infections.
METHODS: Combined infection reduction and antibiotic stewardship protocols were implemented in the surgical and trauma intensive care units at Vanderbilt University Hospital beginning in 2002. The components of the program were: (1) Protocol-specific empiric and therapeutic antibiotics for healthcare-acquired infections; (2) surgical antibiotic prophylaxis protocols; and (3) quarterly rotation/limitation of dual antibiotic classes. Continuous healthcare-acquired infection surveillance was conducted by independent practitioners using National Heath Safety Network criteria. Linear regression analysis was used to estimate trends in MDR gram-negative healthcare-acquired infections.
RESULTS: A total of 1,794 gram-negative pathogens were isolated from healthcare-acquired infections during the eight-year observation period. The proportion of healthcare-acquired infections caused by MDR gram-negative pathogens decreased from 37.4% (2001) to 8.5% (2008), whereas the proportion of healthcare-acquired infections caused by pan-sensitive pathogens increased from 34.1% to 53.2%. The rate of total healthcare-associated infections per 1,000 patient-days that were caused by MDR gram-negative pathogens declined by -0.78 per year (95% confidence interval [CI] -1.28, -0.27). The observed rate of healthcare-acquired infections per 1,000 patient days attributable to specific MDR gram-negative pathogens decreased over time: Pseudomonas -0.14 per year (95% CI -0.20, -0.08), Acinetobacter-0.49 per year (95% CI -0.77, -0.22), and Enterobacteriaceae -0.14 per year (95% CI -0.26, -0.03).
CONCLUSION: Implementation of an antibiotic stewardship protocol as a component of an infection reduction campaign was associated with a decrease in resistant gram-negative healthcare-acquired infections in intensive care units. These results further support widespread implementation of such initiatives.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21091186     DOI: 10.1089/sur.2009.059

Source DB:  PubMed          Journal:  Surg Infect (Larchmt)        ISSN: 1096-2964            Impact factor:   2.150


  19 in total

1.  Antimicrobial stewardship: importance for patient and public health.

Authors:  Thomas M File; Arjun Srinivasan; John G Bartlett
Journal:  Clin Infect Dis       Date:  2014-10-15       Impact factor: 9.079

Review 2.  Antibiotic stewardship programmes in intensive care units: Why, how, and where are they leading us.

Authors:  Yu-Zhi Zhang; Suveer Singh
Journal:  World J Crit Care Med       Date:  2015-02-04

Review 3.  Antimicrobial Stewardship: How the Microbiology Laboratory Can Right the Ship.

Authors:  Philippe Morency-Potvin; David N Schwartz; Robert A Weinstein
Journal:  Clin Microbiol Rev       Date:  2016-12-14       Impact factor: 26.132

Review 4.  [Antibiotic stewardship : A programmatic approach to improved antimicrobial management].

Authors:  Martin Müller; Patrick Lehmann; Christian Willy
Journal:  Unfallchirurg       Date:  2017-07       Impact factor: 1.000

5.  Multi-Drug-Resistant Gram-Negative Infections in Deployment-Related Trauma Patients.

Authors:  Wesley R Campbell; Ping Li; Timothy J Whitman; Dana M Blyth; Elizabeth R Schnaubelt; Katrin Mende; David R Tribble
Journal:  Surg Infect (Larchmt)       Date:  2017-02-24       Impact factor: 2.150

6.  Toward a structome of Acinetobacter baumannii drug targets.

Authors:  Logan M Tillery; Kayleigh F Barrett; David M Dranow; Justin Craig; Roger Shek; Ian Chun; Lynn K Barrett; Isabelle Q Phan; Sandhya Subramanian; Jan Abendroth; Donald D Lorimer; Thomas E Edwards; Wesley C Van Voorhis
Journal:  Protein Sci       Date:  2020-01-20       Impact factor: 6.725

7.  Factors Associated With Prolonged Antibiotic Use in the Setting of Suspected Pneumonia and Negative Bronchoalveolar Lavage Cultures.

Authors:  Jonathon D Pouliot; Marcus J Dortch; Gabrielle Givens; William Tidwell; Susan E Hamblin; Addison K May
Journal:  Hosp Pharm       Date:  2020-05-05

8.  A Refunding Scheme to Incentivize Narrow-Spectrum Antibiotic Development.

Authors:  Lucas Böttcher; Hans Gersbach
Journal:  Bull Math Biol       Date:  2022-04-22       Impact factor: 3.871

Review 9.  An Argument for the Use of Aminoglycosides in the Empiric Treatment of Ventilator-Associated Pneumonia.

Authors:  Addison K May
Journal:  Surg Infect (Larchmt)       Date:  2016-04-01       Impact factor: 2.150

10.  Targeted Treatment for Bacterial Infections: Prospects for Pathogen-Specific Antibiotics Coupled with Rapid Diagnostics.

Authors:  Tucker Maxson; Douglas A Mitchell
Journal:  Tetrahedron       Date:  2015-10-09       Impact factor: 2.457

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.